NCT04434963

Safety and Feasibility of Reversible Induction Strategy

Safety and Feasibility of Reversible Induction Strategy Supported by HFNC Combined With Specific Anesthetic

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 20 (estimated)
• Sponsor: RenJi Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study would explore the safety and feasibility of a reversible induction strategy for uncertain difficult airway. This reversible induction strategy would include high flow nasal canular oxygenation support, short-term effect anesthetic including Propofol and Remifentanil for sedation and analgesia and Sugammadex would be used for reverse the muscle relaxant.

Conditions

• Patients With Uncertain Difficult Airway
• Colon Cancer
• Gastric Cancer
• Prostatic Cancer

Timeline

• Start date: 2021-02-01
• Primary completion: 2021-12-01
• Completion: 2021-12-01
• First posted: 2020-06-17
• Last updated: 2021-09-14

Locations

1 site across 1 country: China